An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)
Clinical trial NCT04145531 · COMPLETED
Trial details
- NCT number
- NCT04145531
- Sponsor
- Jazz Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-27
- Primary completion
- 2022-07-13
- Enrollment
- 229
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.